The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
Masatake Kurita,1–3 Satoshi Nishino,1,2 Yukio Numata,1 Yoshiro Okubo,3 Tadahiro Sato11Sato Hospital, Koutokukai, Nanyo, Yamagata, Japan; 2Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan; 3Department of Psychiatry and B...
Guardado en:
Autores principales: | Kurita M, Nishino S, Numata Y, Okubo Y, Sato T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c29268972e3d4c6990d48b41bbd63425 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
por: Kurita M
Publicado: (2016) -
Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China
por: Liu Y, et al.
Publicado: (2020) -
QT and P-wave dispersion during the manic phase of bipolar disorder
por: Gurok MG, et al.
Publicado: (2019) -
The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili M, et al.
Publicado: (2011) -
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
por: Takeyoshi K, et al.
Publicado: (2016)